FDA to Authorize Third Dose of Pfizer Vaccine for Older Americans

The U.S. Food and Drug Administration will authorize a booster dose of the Pfizer Inc and BioNTech COVID-19 vaccine for those aged 65 and older and some high-risk Americans, a Bloomberg News report said on Wednesday.The move would pave the way for a quick rollout of the…